Condition: Bladder Cancer, Muscle Invasive Bladder Cancer (MIBC), Muscle Invasive Bladder Cancer Urothelial Carcinoma, Cystectomy

Study Type: Interventional

Clinical Trials Identifier NCT 8-digits: NCT07225205

Sponsor: Johns Hopkins University

Eligibility:

• Age: minimum 18 Years maximum N/A
• Gender: All

Inclusion Criteria:

• Adult patients greater than 18 years of age and older
• Confirmed urothelial carcinoma on pathology, including muscle invasive, non-muscle invasive, and variant histology
• Patient electing to undergo radical cystectomy with bilateral pelvic lymphadenectomy after counseling with a urologic oncologist.

Exclusion Criteria:

• Patients undergoing radical cystectomy for benign indications (e.g. chronic bladder pain, fistulas, severe lower urinary tract symptoms)
• Patients undergoing radical cystectomy for a non-bladder primary malignancy (e.g. rectal, colon, uterine cancers).
• Patients with extensive locally advanced disease necessitating a pelvic exenteration
• Contraindication to receiving home IVF therapy (i.e. pre-existing cardiac, renal, hepatic dysfunction)
• Unwilling or unable to participate in 30 and 90 day follow-up phone calls.

View trial on ClinicalTrials.gov